Recently, we reported that DEF8 presents a neuronal profile in the central nervous system (CNS) in a murine transgenic AD model and shows a differential expression in peripheral blood mononuclear cells (PBMC) from patients with MCI and early-stage AD22. This evidence concerns the gene DEF8 and Alzheimer disease.